Genomind is a company developing a personalized medicine platform for clinicians, healthcare partners, and individuals. Its test, the Genecept Assay, is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, obsessive-compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD), bipolar and post-traumatic stress disorder (PTSD), autism, schizophrenia, etc.